Reactome | PD 0325901 [cytosol]

Schema > ChemicalDrug > Entries

candidateOf	[CandidateSet:R-ALL-9657574] single mechanism MAP2K1/2 inhibitors [cytosol]
compartment	[Compartment:70101] cytosol
created	[InstanceEdit:9657554] Rothfels, Karen, 2019-08-08
crossReference	[DatabaseIdentifier:12020745] Mondo:0004992 [DatabaseIdentifier:9657555] ChEBI:88249
dbId	9657553
disease	[Disease:1500689] cancer
displayName	PD 0325901 [cytosol]
inDisease	true
literatureReference	[LiteratureReference:9657358] Disruption of CRAF-mediated MEK activation is required for effective MEK inhibition in KRAS mutant tumors
maxDepth	1
name	PD 0325901
referenceEntity	[ReferenceTherapeutic:iuphar.ligand:7935] PD 0325901 [Guide to Pharmacology:7935]
schemaClass	ChemicalDrug
stId	R-ALL-9657553

(hasCandidate)

Cite Us!